Microscopic observation drug-susceptibility assay vs. Xpert® MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis

Nav

General Info

Geography

Mozambique (MOZ)

Coverage type

Country

Time period covered

01/2000 - 12/2014

Data type

Scientific literature

Keywords

DALYs, Diagnostic equipment, Health care costs, Health care economics, Health care expenditures, Tuberculosis

Citation

Authors

Wikman-Jorgensen PE, Llenas-García J, Pérez-Porcuna TM, Hobbins M, Ehmer J, Mussa MA, Ascaso C

Journal

Trop Med Int Health

Volume

Issue

Pages

734-743

Publication year

2017

Suggested citation

Wikman-Jorgensen PE, Llenas-García J, Pérez-Porcuna TM, Hobbins M, Ehmer J, Mussa MA, Ascaso C. Microscopic observation drug-susceptibility assay vs. Xpert® MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis. Trop Med Int Health. 2017; 22(6): 734-743.

DOI

10.1111/tmi.12879

PMID

28380276

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Microscopic observation drug-susceptibility assay vs. Xpert® MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis

Nav